Regeneron Pharmaceuticals Inc (REGN) financials · P/E 20, rev $14.34B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Regeneron Pharmaceuticals Inc (REGN) P/E 20, rev $14.34B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $14.34B | $14.20B |
| Operating Income | $3.58B | $3.99B |
| Net Income | $4.50B | $4.41B |
| EPS (Diluted) | $41.48 | $38.34 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $40.56B | $37.76B |
| Current Assets | $18.02B | $18.66B |
| Cash & Equivalents | $3.12B | $2.49B |
| Inventory | $3.20B | $3.09B |
| Total Liabilities | $9.30B | $8.41B |
| Current Liabilities | $4.37B | $3.94B |
| Long-term Debt | $1.99B | $1.98B |
| Total Debt | $1.99B† | $1.98B† |
| Shareholders' Equity | $31.26B | $29.35B |
| Retained Earnings | $35.80B | $31.67B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $4.98B | $4.42B |
| CapEx | $898.4M | $755.9M |
| Investing Cash Flow | -$629.1M | -$2.47B |
| Financing Cash Flow | -$3.72B | -$2.20B |
| Dividends Paid | $370.3M | $0 |
| Net Change in Cash | $634.7M | -$248.8M |
| Free Cash Flow | $4.08B | $3.66B |
FAQ
What is REGN P/E and revenue?
Regeneron Pharmaceuticals Inc (REGN) P/E 20, rev $14.34B.
What is REGN revenue?
Regeneron Pharmaceuticals Inc last cached revenue is $14.34B (FY2025).
Is REGN profitable?
Regeneron Pharmaceuticals Inc last cached net income is $4.50B (FY2025).
What are REGN total assets?
Regeneron Pharmaceuticals Inc last cached total assets are $40.56B (FY2025).
What is REGN free cash flow?
Regeneron Pharmaceuticals Inc last cached free cash flow is $4.08B (FY2025).
Not investment advice. Cached statements, not a live tape.